Crossref
Preclinical safety assessments of mRNA-targeting oligonucleotide therapeutics
Translational and Regulatory Sciences · 2020 · 2 (3) · 90-93
DOI: 10.33611/trs.2020-010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational and Regulatory Sciences, 2020. Verfasst von Kazushige MAKI. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
MAKI, K. (2020). Preclinical safety assessments of mRNA-targeting oligonucleotide therapeutics. Translational and Regulatory Sciences, 2(3), 90-93. https://doi.org/10.33611/trs.2020-010
Vancouver
MAKI K. Preclinical safety assessments of mRNA-targeting oligonucleotide therapeutics. Translational and Regulatory Sciences. 2020;2(3):90-93. doi:10.33611/trs.2020-010
BibTeX
@article{MAKI2020,
author = {MAKI, Kazushige},
title = {Preclinical safety assessments of mRNA-targeting oligonucleotide therapeutics},
journal = {Translational and Regulatory Sciences},
year = {2020},
volume = {2},
number = {3},
pages = {90--93},
doi = {10.33611/trs.2020-010}
}
EUVIMED